Avrobio Inc (AVRO)

3.90 -0.18  -4.41% NASDAQ Nov 29, 10:48 USD
View Full Chart
Price Chart
View All AVRO News

News

View All Events

Events

Date Type Description
03/18/2022 Earnings Results Q4 2021 Earnings Results
11/04/2021 Earnings Results Q3 2021 Earnings Results
08/05/2021 Earnings Results Q2 2021 Earnings Results
06/10/2021 09:00 EST AGM 2021 Annual General Meeting
05/13/2021 Earnings Results Q1 2021 Earnings Results
03/18/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-01, AVR-RD-02, AVR-RD-03, and AVR-RD-04 which are used for various diseases such as Fabry, Gaucher, Pompe, and Cystinosis.
  • URL: https://www.avrobio.com
  • Investor Relations URL: https://investors.avrobio.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Mar. 18, 2022
  • Last Earnings Release: Nov. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.